Glatiramer acetate(CAS: 147245-92-9)

Glatiramer acetate (CAS 147245-92-9) is regulated by various guidelines including REACH in the European Union, and FDA and EPA in the United States. It is classified according to the Globally Harmonized System (GHS) as non-hazardous. Specific regulations may vary based on the intended use and geographical region.

There are no direct alternatives to Glatiramer acetate (CAS 147245-92-9) in synthesis, as it is a unique compound with specific properties. However, similar compounds like copolymer-1 and other demyelination therapies can be explored as alternatives for similar therapeutic applications.

The market for Glatiramer acetate (CAS 147245-92-9) is stable but shows trends towards increased research in multiple sclerosis treatments. There is ongoing interest in understanding its mechanisms and exploring its potential in other autoimmune diseases. Market trends indicate a need for more comprehensive understanding and possibly improved formulations.

Waste containing Glatiramer acetate (CAS 147245-92-9) should be collected in sealed containers and disposed of according to local regulations. For large quantities or specialized handling, it is advisable to contact a professional waste disposal service. Ensure all waste is properly labeled and stored to prevent environmental contamination.